Skip to main content
Gut logoLink to Gut
. 1973 Apr;14(4):316–318. doi: 10.1136/gut.14.4.316

Bile acids and vitamin A absorption in man: the effects of two bile acid-binding agents, cholestyramine and lignin

D L Barnard, K W Heaton
PMCID: PMC1412596  PMID: 4706914

Abstract

In 14 healthy volunteers, the addition of 12 g cholestyramine to a vitamin A-containing test meal reduced the expected rise in serum vitamin A by 59·5% (p<0·001). By contrast, lignin had no significant effect in 12 subjects. This study confirms the importance of bile acids in vitamin A absorption and the ineffectiveness of lignin as a sequestrator of conjugated bile acids.

Full text

PDF
316

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eastwood M. A., Girdwood R. H. Lignin: a bile-salt sequestrating agent. Lancet. 1968 Nov 30;2(7579):1170–1172. doi: 10.1016/s0140-6736(68)91643-7. [DOI] [PubMed] [Google Scholar]
  2. Eastwood M. A., Hamilton D. Studies on the adsorption of bile salts to non-absorbed components of diet. Biochim Biophys Acta. 1968 Jan 10;152(1):165–173. doi: 10.1016/0005-2760(68)90018-0. [DOI] [PubMed] [Google Scholar]
  3. Gross L., Brotman M. Hypoprothrombinemia and hemorrhage associated with cholestyramine therapy. Ann Intern Med. 1970 Jan;72(1):95–96. doi: 10.7326/0003-4819-72-1-95. [DOI] [PubMed] [Google Scholar]
  4. Heaton K. W., Heaton S. T., Barry R. E. An in vivo comparison of two bile salt binding agents, cholestyramine and lignin. Scand J Gastroenterol. 1971;6(3):281–286. doi: 10.3109/00365527109180709. [DOI] [PubMed] [Google Scholar]
  5. Heaton K. W., Lever J. V., Barnard D. Osteomalacia associated with cholestyramine therapy for postileectomy diarrhea. Gastroenterology. 1972 Apr;62(4):642–646. [PubMed] [Google Scholar]
  6. Johns W. H., Bates T. R. Quantification of the binding tendencies of cholestyramine. II. Mechanism of interaction with bile salt and fatty acid salt anions. J Pharm Sci. 1970 Mar;59(3):329–333. doi: 10.1002/jps.2600590311. [DOI] [PubMed] [Google Scholar]
  7. Thiffault C., Bélanger M., Pouliot M. Traitement de l'hyperlipoproténémie essentielle de type II par un nouvel agent thérapeutique, la celluline. Can Med Assoc J. 1970 Jul 18;103(2):165–166. [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES